Immunic reported 0 in Sales Revenues for its fiscal quarter ending in June of 2024.





Sales Change Date
Alterity Therapeutics Limited AUD 596.04K 584.66K Dec/2025
BioMarin Pharmaceutical USD 766M 109M Mar/2026
Cipla INR 65.41B 9.77B Mar/2026
Clal Biotechnology ILS 3.41M 2M Dec/2022
Compugen USD 6.35M 60.98M Mar/2026
CSL USD 8.33B 4.79B Dec/2025
Enanta Pharmaceuticals USD 16.96M 50.68M Dec/2024
Grifols EUR 2B 306.7M Mar/2026
Insmed USD 305.96M 42.16M Mar/2026
OraSure Technologies USD 26.76M 322K Dec/2025
Quidel USD 620M 104M Mar/2026
Ultragenyx Pharmaceutical USD 136M 71M Mar/2026
United Therapeutics USD 781.5M 8.7M Mar/2026
Xoma USD 25K 5M Sep/2024